Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2000
View Archived Issues
Roche and Aventis collaborate on Herceptin/Taxotere combination research
Read More
Health Canada approves Asmanex Twisthaler for treatment of asthma
Read More
Cyclacel and CV Therapeutics join forces to screen anticancer compounds
Read More
Protegrin IB-367 enters phase II for prevention of ventilator-associated pneumonia
Read More
Amylin seeks FDA approval for Symlin as adjuvant treatment in diabetes
Read More
Efficacy/safety of Campath-1H in acute and chronic leukemias reported at ASH meeting
Read More
Early clinical results for bryostatin 1 in hematological malignancies encouraging
Read More
Myriad Genetics obtains license to cancer drug in phase II
Read More
IL-2 variant with T-cell selectivity displays antitumor activity and good tolerance in animals
Read More
Celgene and NCI sign CRADA for development of anticancer compounds
Read More
SB-222200 is a potential new tool for studies on the NK3 receptor
Read More
Phase II clinical trial of 2ME2 commences at Mayo Clinic
Read More
FDA approves new indications for Prevacid
Read More
MR-33 as a potential treatment for DIC with reduced hemorrhagic risk
Read More
EMEA hands down positive opinion for Rapamune
Read More
GSAO, a novel molecule with the potential to take on both cancer and HIV
Read More
Lundbeck's insomnia drug enters phase II
Read More
Acadia and Allergan discover novel treatment for chronic pain
Read More
Glaxo Wellcome/SmithKline Beecham merger expected to be finalized in late December
Read More
Nonpeptide cathepsin D inhibitors identified at U. of California
Read More
Novel catechol-based COMT inhibitors designed by Orion research group
Read More
Zometa now available in Canada for hypercalcemia of malignancy
Read More
Amylin patents new PEG-modified exendins, exendin agonists
Read More
Catechols and prolines under study at Merck and Cubist as antimicrobial agents
Read More
Preparation and use of nonsteroidal glucocorticoid receptor modulators described by Pfizer
Read More
New MAb prepared at CNRS useful in RCC therapy, diagnosis
Read More
Galenic formulations of antithrombotic agents for s.c. administration
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe